GDC IT Solutions Attains Kentico Partner Status

 Today, GDC IT Solutions (GDC), a leading provider in technology solutions, announced its newest partnership with Kentico, the award-winning provider of digital experience platforms. The new partnership will enable clients across the US to grow their digital presence with Xperience by Kentico.

Xperience by Kentico is Kentico’s hybrid headless digital experience platform that allows marketers to craft consistent personalized customer journeys from awareness to advocacy using built-in low-code, no-code tools. They can experiment with innovative marketing channels and improve the maturity of their marketing ecosystem, while enhancing business and marketing agility.

“By enabling teams to do more with less and in less time, Xperience by Kentico not only gets brands to market faster and with all the tools they need to engage customers across multiple channels, but it empowers them to compete with their rivals no matter where they are in their digital maturity journey,” said Dominik Pinter, CEO of Kentico. “We are thrilled to collaborate with such a forward-thinking company and look forward to seeing how clients will benefit from our new partnership with GDC.”

“Kentico is essential to the growth of GDC’s strategic omni-channel marketing solution and integration offerings. The Xperience by Kentico Digital Experience Platform (DXP) and support from the Kentico team will help us deliver on brand digital experiences,” said C.J. Kozarski, Sr. Director of Application Services, GDC IT Solutions. “Implementing and adopting appropriate digital technologies will help us to efficiently leverage our domain expertise to offer well-integrated and affordable solutions with rapid implementation/migration, quick turnaround, and easy deployment on the cloud.”

About Kentico

Kentico is an award-winning provider of digital experience platforms that enable businesses to drive better outcomes with fewer resources using a hybrid headless approach for multichannel digital experiences. Its digital experience platform (DXP), Xperience by Kentico, minimizes overhead by focusing on real customer needs. With a wide set of capabilities, it empowers teams to deliver better customer experiences through multiple channels faster. Kentico offers market-leading support, SaaS or on-premises deployment, and is backed by a global network of implementation partners.  

Kentico was founded in 2004 and is headquartered in the Czech Republic with offices in the US, UK, Germany, and Australia. Kentico has more than five hundred digital solution partners and powers over 35,000 websites across 120 countries. Customers working with Kentico include Allergan, Ingram Micro, Konica Minolta, Land O’ Lakes, PPG, and Red Cross. Learn more at

About GDC IT Solutions

GDC IT Solutions empowers businesses to increase employee productivity, maximize investments and improve operational efficiencies. With experienced and certified professionals, GDC delivers services in the areas of application development, data center, 24/7 multilingual service desk, managed IT services, desktop lifecycle management, project management, and business process consulting. Learn more at

Jonathan Henault
+420 608 561 854
Head of Brand



  • Software

Vesalio Attains Key FDA Clinical Study Milestone

Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL(1) clinical trial, assessing the company’s NeVa VS™ technology in the treatment of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH), has been completed.

Cerebral vasospasm is an intense and prolonged narrowing of the arteries that develops gradually over the first few days following aneurysm rupture. This narrowing can reduce blood flow and is considered to be one of the leading causes of death after such ruptures. Current treatment for vasospasm includes endovascular administration of intra-arterial vasodilators and balloon angioplasty, utilized off-label for this indication. Currently, there is no medical technology cleared for the treatment of vasospasm in the United States.

“Completion of this IDE study is a significant step forward in our drive to provide the first FDA cleared technology to treat this patient population. We look forward to working with the FDA in the next step of the regulatory process,” stated Steve Rybka, CEO of Vesalio.

(1) VITAL refers to “The Vesalio NeVa VS for the treatment of symptomatic Cerebral Vasospasm following aneurysmal subarachnoid haemorrhage (aSAH).”

Founded in 2013, Vesalio is a privately held medical device company focused on advancing patient care in vascular occlusion by providing physicians superior technology designed to improve clinical outcomes. The Company’s proprietary NeVa™ platform was designed to consistently achieve first-pass recanalization in acute ischemic stroke by effectively removing all types of neurovascular clots from patient anatomy.

For further information, visit or email NeVa trademark and patents are the property of Vesalio.